If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

Share Price is delayed by 15 minutes
Get Live Data
333.50    0.00 (0.00%)
Bid:
332.00
Ask:
335.00
Spread: 3.00 (0.904%)
Market Cap: £230.27m
ANCR Live PriceLast checked at - London Stock Exchange

Intraday Animalcare Grp Share Chart

Form 8.5 (EPT/RI)

24 Jun 2026 10:38

RNS Number : 5869J
Panmure Liberum Limited
24 June 2026
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Liberum Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Animalcare Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Animalcare Group plc

(d) Date dealing undertaken:

23 Jun 2026

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

20p ordinary

Purchase

3,514

3.32351 GBP

3.3233 GBP

20p ordinary

Sales

25,000

3.325 GBP

3.325 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

24/06/2026

Contact name:

Shivani Ghiraiya

Telephone number:

+44 (0) 20 3100 2213

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFZGZVLDVGVZG
Date   Source Headline
2nd Jun 201410:31 amRNSHolding(s) in Company
23rd May 20146:35 pmRNSHolding(s) in Company
15th May 20146:00 pmRNSDirector/PDMR Shareholding
11th Apr 20146:05 pmRNSHolding(s) in Company
4th Apr 20143:58 pmRNSAdditional Listing
26th Feb 20147:00 amRNSHalf Yearly Report
5th Feb 201411:33 amRNSDirector/PDMR Shareholding
16th Jan 20146:17 pmRNSHolding(s) in Company
15th Jan 20147:00 amRNSTrading Update & Notice of Results
8th Jan 20144:09 pmRNSAdditional Listing
24th Dec 201312:30 pmRNSAdditional Listing
17th Dec 20134:24 pmRNSDirector/PDMR Shareholding
5th Nov 20133:50 pmRNSAdditional Listing
5th Nov 20132:20 pmRNSResult of AGM
5th Nov 20137:00 amRNSAGM Statement
11th Oct 20134:14 pmRNSAnnual Report and Accounts and Notice of AGM
25th Sep 20137:00 amRNSFull Year Results
10th Jul 20137:00 amRNSPre-Close Trading Update
27th Jun 20133:31 pmRNSGrant of Options
27th Jun 20137:00 amRNSChange of Adviser
18th Apr 20133:17 pmRNSDirector/PDMR Shareholding
10th Apr 201312:50 pmRNSHolding(s) in Company
5th Apr 201311:06 amRNSDirector Shareholding
15th Mar 20138:15 amRNSChange of Registered Office
4th Mar 20131:10 pmRNSHolding(s) in Company
21st Feb 20131:00 pmRNSGrant of Share Options
21st Feb 20137:00 amRNSHalf Yearly Report
11th Jan 20137:00 amRNSDirectorate Change
11th Jan 20137:00 amRNSPost-Close Trading Update & Notice of Results
3rd Jan 20137:00 amRNSSale of Buprecare ampoules resumed
21st Dec 20125:55 pmRNSDirector/PDMR Shareholding
19th Dec 20128:39 amRNSShare Allotment and Total Voting Rights
21st Nov 20126:30 pmRNSGrant of Share Options
6th Nov 20124:47 pmRNSResult of AGM
6th Nov 20127:00 amRNSAGM Statement
29th Oct 20127:00 amRNSChange of Name of Adviser
12th Oct 20129:15 amRNSAnnual Report and Notice of Annual General Meeting
5th Oct 20121:44 pmRNSHolding(s) in Company
4th Oct 20127:00 amRNSFinal Results
4th Oct 20127:00 amRNSGranting of a Marketing Authorisation
6th Sep 20127:00 amRNSLaunch of New Veterinary Medicine
3rd Aug 20121:51 pmRNSGrant of Share Options
11th Jul 20127:00 amRNSPre-Close Trading Update
25th Jun 201210:05 amRNSReplacement re Grant of Share Options
25th Jun 20127:00 amRNSGrant of Share Options
24th May 20127:00 amRNSTrading update
1st May 20126:11 pmRNSShare Allotment and Total Voting Rights
30th Mar 20126:09 pmRNSTotal Voting Rights
28th Mar 20125:02 pmRNSHolding(s) in Company
23rd Mar 20127:00 amRNSMarketing Authorisation for Project Quattro

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.